These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19307800

  • 21. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients.
    Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F.
    Liver Transpl; 2008 Jul; 14(7):946-55. PubMed ID: 18581476
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

  • 23. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM.
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [Abstract] [Full Text] [Related]

  • 24. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S, Lampela H, Jalanko H, Mäkisalo H, Lohi J, Arola J, Pakarinen MP.
    Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
    [Abstract] [Full Text] [Related]

  • 25. Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection.
    Robaeys G, Nevens F, Stärkel P, Colle I, Van Eyken P, Bruckers L, Van Ranst M, Buntinx F.
    Transplant Proc; 2009 Mar; 41(2):589-94. PubMed ID: 19328933
    [Abstract] [Full Text] [Related]

  • 26. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, Iguchi T, Hashimoto N, Maehara Y.
    Transplantation; 2009 Aug 15; 88(3):303-7. PubMed ID: 19667930
    [Abstract] [Full Text] [Related]

  • 27. Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation.
    Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T.
    Liver Transpl; 2005 May 15; 11(5):547-54. PubMed ID: 15838883
    [Abstract] [Full Text] [Related]

  • 28. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F.
    Transplant Proc; 2009 Mar 15; 41(2):679-81. PubMed ID: 19328955
    [Abstract] [Full Text] [Related]

  • 29. The incidence and management of acute and chronic rejection after living donor liver transplantation.
    Yilmaz F, Aydin U, Nart D, Zeytunlu M, Karasu Z, Kaya T, Ozer I, Yuce G, Aydogdu S, Kilic M.
    Transplant Proc; 2006 Jun 15; 38(5):1435-7. PubMed ID: 16797325
    [Abstract] [Full Text] [Related]

  • 30. Refractory acute rejection in a living related liver transplantation.
    Noritomi T, Sugawara Y, Kaneko J, Matsui Y, Makuuchi M.
    Hepatogastroenterology; 2003 Jun 15; 50(54):2192-3. PubMed ID: 14696495
    [Abstract] [Full Text] [Related]

  • 31. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
    Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM.
    Liver Transpl; 2004 Apr 15; 10(4):480-7. PubMed ID: 15048789
    [Abstract] [Full Text] [Related]

  • 32. Progressive histological damage in liver allografts following pediatric liver transplantation.
    Evans HM, Kelly DA, McKiernan PJ, Hübscher S.
    Hepatology; 2006 May 15; 43(5):1109-17. PubMed ID: 16628633
    [Abstract] [Full Text] [Related]

  • 33. What does the long-term liver allograft look like for the pediatric recipient?
    Hübscher S.
    Liver Transpl; 2009 Nov 15; 15 Suppl 2():S19-24. PubMed ID: 19877293
    [Abstract] [Full Text] [Related]

  • 34. Influence of donor age on survival in liver transplantation due to hepatitis C virus.
    Tallón Aguilar L, Molina García D, Barrera Pulido L, Pareja Ciuró F, Suárez Artacho G, Alamo Martínez JM, Bernal Bellido C, García González I, Serrano Díaz-Canedo J, Gómez Bravo MA, Bernardos Rodríguez A.
    Transplant Proc; 2008 Nov 15; 40(9):2968-70. PubMed ID: 19010162
    [Abstract] [Full Text] [Related]

  • 35. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R, Asonuma K, Zeledon Ramirez ME, Yoshimoto K, Nishimori A, Inomata Y.
    Exp Clin Transplant; 2009 Mar 15; 7(1):8-12. PubMed ID: 19364305
    [Abstract] [Full Text] [Related]

  • 36. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.
    Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH.
    Transplantation; 2009 Apr 27; 87(8):1174-9. PubMed ID: 19384164
    [Abstract] [Full Text] [Related]

  • 37. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome.
    Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T.
    Transpl Int; 2009 Mar 27; 22(3):303-12. PubMed ID: 19040488
    [Abstract] [Full Text] [Related]

  • 38. Graft fibrosis in stable pediatric liver transplant recipients: what does it mean?
    Magee JC.
    Hepatology; 2009 Mar 27; 49(3):726-8. PubMed ID: 19241487
    [No Abstract] [Full Text] [Related]

  • 39. Chronic liver transplant rejection: definition and diagnosis.
    Wight DA.
    Transplant Proc; 1996 Feb 27; 28(1):465-7. PubMed ID: 8644314
    [No Abstract] [Full Text] [Related]

  • 40. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.
    Banff Working Group on Liver Allograft PathologyUniversity of Pittsburgh Medical Center, 3459 5th Avenue, UPMC Montefiore E741, Pittsburgh, PA 15213, USA..
    Liver Transpl; 2012 Oct 27; 18(10):1154-70. PubMed ID: 22645090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.